Trades on 1 secondary market

Xaira

Xaira Therapeutics is a South San Francisco-based biotechnology company building the transformative artificial intelligence that discovers and develops the next generation of medicines. Founded in 2023 and launched publicly in 2024 out of ARCH Venture Partners and Foresight Labs, Xaira couples large

emerging 15.6 / 100 0 APIs View provider profile →

Company Biotechnology Artificial Intelligence Drug Discovery Machine Learning Protein Design

Xaira is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.